"Receptors, Interleukin-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.
| Descriptor ID |
D015375
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.320
|
| Concept/Terms |
Receptors, Interleukin-2- Receptors, Interleukin-2
- Receptors, Interleukin 2
- TCGF Receptor
- TCGF Receptors
- Receptors, TCGF
- IL-2 Receptor
- IL 2 Receptor
- Receptor, IL-2
- IL-2 Receptors
- IL 2 Receptors
- T-Cell Growth Factor Receptor
- T Cell Growth Factor Receptor
- IL2 Receptors
- Receptors, IL2
- Interleukin 2 Receptor
- Receptor, Interleukin 2
- Interleukin-2 Receptors
- Interleukin 2 Receptors
- Receptor, TCGF
- Receptors, IL-2
- Receptors, IL 2
- Receptors, T-Cell Growth Factor
- Receptors, T Cell Growth Factor
- T-Cell Growth Factor Receptors
- T Cell Growth Factor Receptors
- IL2 Receptor
- Receptor, IL2
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-2".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-2".
This graph shows the total number of publications written about "Receptors, Interleukin-2" by people in this website by year, and whether "Receptors, Interleukin-2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 3 | 4 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 2 | 3 |
| 1998 | 2 | 2 | 4 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 5 | 6 |
| 2003 | 5 | 3 | 8 |
| 2004 | 2 | 3 | 5 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-2" by people in Profiles.
-
Signaling function of PRC2 is essential for TCR-driven T cell responses. J Exp Med. 2018 04 02; 215(4):1101-1113.
-
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol. 2010 Nov 20; 28(33):4969-75.
-
Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int. 2008 Jul; 21(7):625-36.
-
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation. 2007 Jun 15; 83(11):1429-34.
-
Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection. Chest. 2007 Feb; 131(2):533-8.
-
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. J Neurosurg. 2006 Sep; 105(3):430-7.
-
Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. J Immunother. 2006 Jul-Aug; 29(4):416-24.
-
Persistent inflammation and hyperresponsiveness following viral rhinosinusitis. Laryngoscope. 2006 Jul; 116(7):1236-40.
-
The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol. 2006 Mar; 59(3):298-302.
-
CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J Immunol. 2005 Dec 15; 175(12):7889-97.